GLICLAZID Spirig HC Retard cpr ret 60 mg 30 pce
7680654410016
CH-65441
A10BB09
07.06.2.
Reimbursement limitations:
DIAMICRON
Pris en charge lorsque la metformine ne permet pas un contrôle suffisant de la glycémie.
…
1 / 3
google
Details
- Product number
- 6544102
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- gliclazidum 60 mg, lactosum monohydricum 163.8 mg, hypromellosum, magnesii stearas, pro compresso.
Articles (1)
Gliclazid Spirig HC Retard 60 mg, Tabletten mit veränderter Wirkstofffreisetzung
Tabletten mit veränderter Wirkstofffreisetzung
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
163.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 17.45
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2015
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 65441
- Drug name
- Gliclazid Spirig HC Retard, Tabletten mit veränderter Wirkstofffreisetzung
- Galenic form
- RETT
- ATC Code
- A10BB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 09/06/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GLICLAZID Spirig HC Retard cpr ret 60 mg 30 pce
- Description (DE)
- GLICLAZID Spirig HC Retard Ret Tabl 60 mg 30 Stk
- Market launch
- 09/06/2015
- Narcotic (BTM)
- No